MarketInOut Stock Screener Log In | Sign Up

Rhythm Biosciences Ltd

Healthcare • Diagnostics & Research • Quote as of 10/29/2026 10:49
Rhythm Biosciences Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
Market Capitalization23 mln
Float328 mln
Earnings Date02/24/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.45
Highly suspicious

1-Year Forecast

0.535
Transformational upside

Relative Strength

27 / 100
Underperforming

Debt / Equity

0.07
Debt-free

Pre-Tax Margin

-8,795%
Severely loss-making

Business Description

Rhythm Biosciences is an Australian diagnostics company focused on making cancer detection simpler through blood-based testing. Its two key products are ColoSTAT, which screens for colorectal cancer at an early stage, and geneType, which helps assess an individual's risk of developing chronic disease. Founded in 2017 and based in Parkville, Australia, the company operates across both the Australian and US markets.

Key Fundamentals

EPS-0.02
ROE-276
RPS0.00
ROIC-347
ROA-166
Interest Cover-99.70
EBITDA, mln-7.24
EV / EBITDA-2.59
EV / EBIT-2.52
Revenue, mln0.09
EV / Revenue221

Quote Details

Last 0.066
Change 0.001 (1.54%)
Open 0.066
Volume 22,636
Turnover 1,493.98
Average Volume 206,375

Financial Ratios

Pre-Tax Profit Margin-8,795
Leverage Ratio1.31
Current Ratio3.61
Price / Book6.50
Price / Tangible Book6.50
Debt / Equity0.07
Price / Sales270

Financial Strength

Altman Z-Score-6.17
Piotroski F-Score 5 / 9
Beneish M-Score-0.45
1-Year Target Price0.535

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.49% 25 / 100   
1 Month -18.52% 15 / 100   
2 Months -26.67% 12 / 100   
6 Months -51.11% 8 / 100   
1 Year -31.25% 25 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog